# Transcription Factors in Stimulant and Opioid Action

> **NIH NIH P01** · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · 2024 · $240,463

## Abstract

PROJECT SUMMARY/ABSTRACT – PROJECT 1
 Project 1 focuses on several transcription factors that mediate the lasting actions of stimulants and opioids
in the nucleus accumbens (NAc) and dorsal striatum. Virtually all prior studies of transcription factors in drug
addiction used a candidate approach. This includes ∆FOSB and CREB, which are among the best studied
transcription factors in addiction and first investigated based on “hunches” of their involvement. This is in
marked contrast to a wholly unbiased approach to deduce, in an open-ended manner, those factors that are
most important in the addiction phenotype. During the first funding period, we utilized this approach by taking
advantage of large-scale RNAseq datasets, from rodent models and humans with SUDs, to identify those
factors predicted to be important for lasting drug actions. Importantly, while these datasets identified numerous
transcription factors not previously implicated in addiction, they also validated a central role for ∆FOSB, CREB,
and other factors studied previously. We confirmed predictions for new factors by defining a cell-type-specific
role for RXRa, E2F3A, ZFP189, and others in mediating cocaine and opioid action in NAc. We now propose to
complete characterization of RXRa, which plays an especially important role and also provides a translational
opportunity based on small molecule antagonists that could be used clinically. Our data show robust actions of
RXRa in NAc neurons in both male and female mice and rats in controlling neuronal physiology as well as
transcriptional and behavioral responses to cocaine and opioids, importantly, including the demonstration that
an RXRa inhibitor reduces motivation to SA cocaine. We will now further characterize RXRa mechanisms by
use of CUT&RUN—enabling the first mapping of transcription factor binding genome-wide in NAc—as well as
the binding of several other factors, notably, ∆FOSB and CREB. Our goal is to identify key target genes for
each factor in a cell-type-specific manner. Finally, Project 1 is building a novel pipeline to link these transcript-
tion factors not only to cell activity in brain slices but also to cell activity in awake, behaving animals and to
downstream effects on the functioning of the broader brain reward circuitry. Together, this work is revealing
fundamentally new transcriptional mechanisms by which cocaine and opioids produce an addicted state.

## Key facts

- **NIH application ID:** 10934810
- **Project number:** 2P01DA047233-06A1
- **Recipient organization:** ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
- **Principal Investigator:** ERIC J. NESTLER
- **Activity code:** P01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $240,463
- **Award type:** 2
- **Project period:** 2019-02-15 → 2029-05-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10934810

## Citation

> US National Institutes of Health, RePORTER application 10934810, Transcription Factors in Stimulant and Opioid Action (2P01DA047233-06A1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10934810. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*